Company intelligence / Profile preview

Cogniciti

Ownership: Private
Development stage: Commercial

Overview

Cogniciti offers an evidence-based online brain health assessment tool used by over 65,000 adults in more than 50 countries. The tool helps users determine if their memory performance falls within normal age-related ranges or if further medical evaluation may be warranted. It also provides free community workshops focused on brain health education and early detection of dementia risk factors.

Therapeutic areas: Neurology
Modalities: Non-pharmacological therapy (digital cognitive assessment and education)
Industry: Digital Health Medical Devices

Partnerships

Baycrest Health Sciences (parent organization)Academic collaborations with University of Toronto via Baycrest affiliation

Beyond the preview

Go deeper on Cogniciti.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cogniciti.

Explore the full profile